title: Myc/Tgfa-07_Cy3

description:
mAdb experiment ID: 32261
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-07


title: HCC001_Cy3

status: Public on Oct 28 2004

type: RNA

city: Bethesda

first: Snorri

middle: S

last: Thorgeirsson

state: MD

address: 37 Convent Dr. # 4146

department: Laboratory of Experimental Carcinogenesis

country: USA

institute: National Cancer institute/NIH

description:
mAdb experiment ID: 44071

Array Print: Hs-OperonV2-vB1.1p12-060403
Tissue_type: Hepatocellular Carcinoma
Sample: HCC001
Sample_Description: subgroup B

molecule: total RNA

organism: Homo sapiens

source_name: Pooled Normal Liver


title: Myc/Tgfa-04_Cy5

description:
mAdb experiment ID: 32256
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-04

organism: Mus musculus

source_name: Pooled WT Liver


title: HCC016_Cy5

description:
mAdb experiment ID: 39308

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC016
Sample_Description: subgroup B


title: Myc/E2f1-07_Cy3

description:
mAdb experiment ID: 33133
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-07


title: Myc/E2f1-10_Cy3

description:
mAdb experiment ID: 27845
"HCC from Myc/E2f1 double transgenic mouse, no duplication of microarray experiment"
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-10


title: Myc/E2f1-08_Cy3

description:
mAdb experiment ID: 27851
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-08


title: Myc/E2f1-06_Cy5

description:
mAdb experiment ID: 33132
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-06


title: Myc/E2f1-04_Cy5

description:
mAdb experiment ID: 33128
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-04


title: Myc/Tgfa-09_Cy3

description:
mAdb experiment ID: 32377
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-09


title: Myc/E2f1-05_Cy5

description:
mAdb experiment ID: 33130
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-05


title: Myc/E2f1-07_Cy5

description:
mAdb experiment ID: 33134
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-07


title: Myc/E2f1-03_Cy3

description:
mAdb experiment ID: 29254
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-03


title: Myc/E2f1-02_Cy5

description:
mAdb experiment ID: 29158
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-02


title: Myc/E2f1-02_Cy3

description:
mAdb experiment ID: 29157
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-02


title: Myc/E2f1-06_Cy3

description:
mAdb experiment ID: 33131
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-06


title: Myc/Tgfa-06_Cy5

description:
mAdb experiment ID: 32260
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-06


title: Myc/E2f1-03_Cy5

description:
mAdb experiment ID: 29250
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-03


title: Myc/Tgfa-04_Cy3

description:
mAdb experiment ID: 32376
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-04


title: Myc/E2f1-01_Cy3

description:
mAdb experiment ID: 28649
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-01


title: Myc-11_Cy5

description:
mAdb experiment ID: 29522
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-11


title: Myc-11_Cy3

description:
mAdb experiment ID: 29521
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-11


title: Myc/Tgfa-01_Cy3

description:
mAdb experiment ID: 32237
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-01


title: Myc/E2f1-01_Cy5

description:
mAdb experiment ID: 28650
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-01


title: Myc-09_Cy5

description:
mAdb experiment ID: 33409
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-09


title: Myc-10_Cy3

description:
mAdb experiment ID: 29520
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-10


title: Myc/E2f1-04_Cy3

description:
mAdb experiment ID: 33127
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-04


title: Myc-09_Cy3

description:
mAdb experiment ID: 33410
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-09


title: Myc-06_Cy3

description:
mAdb experiment ID: 33406
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-06


title: Myc-07_Cy5

description:
mAdb experiment ID: 26656
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v2p18_092901
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-07


title: Myc-08_Cy3

description:
mAdb experiment ID: 33407
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-08


title: Myc-05_Cy5

description:
mAdb experiment ID: 33404
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-05


title: Myc-05_Cy3

description:
mAdb experiment ID: 33403
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-05


title: Bovine blood gamma/delta T cell stimulation: exp2 data

city: Saint Paul

first: Mingqi

last: Deng

state: MN

address: 1988 Fitch Avenue

department: Veterinary and Biomedical Sciences

institute: University of Minnesota

description:
Blood gamma/delta T cells were purfiied from holstein calves less than six months old. Blood from 4 individual calves were pooled and gamma/delta T cells were purfied by immunomagnetic separation, rested in RPMI medium for 12h, and underwent ConA & hIL-2 stimulation. Total RNAs were extracted by using Trizol reagents. 15 ug of total RNA was used for cDNA synthesis and microarray hybridization.
Keywords = Gamma delta
Keywords = ConA
Keywords = IL-2
Keywords = apoptosis
Lot batch = experiment 2

organism: Bos taurus

source_name: bovine blood gamma/delta T cells: un-stimulated

source_name: bovine blood gamma/delta T cells: ConA & hIL-2 stimulated (6h-post stimulation)


title: Myc-08_Cy5

description:
mAdb experiment ID: 33408
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-08


title: Myc-06_Cy5

description:
mAdb experiment ID: 33405
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-06


title: Myc/E2f1-08_Cy5

description:
mAdb experiment ID: 26575
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v2p18_092901
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-08


title: HCC009_Cy3

description:
mAdb experiment ID: 38594

Array Print: Hs-OperonV2-vB1.1p3-013003
Tissue_type: Hepatocellular Carcinoma
Sample: HCC009
Sample_Description: subgroup B


title: Myc-07_Cy3

description:
mAdb experiment ID: 27613
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-07


title: Myc-10_Cy5

description:
mAdb experiment ID: 29519
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-10


title: E2f1-09_Cy5

description:
mAdb experiment ID: 25582
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v2p18_092901
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-09


title: E2f1-10_Cy3

description:
mAdb experiment ID: 25656
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v2p18_092901
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-10


title: Myc-01_Cy3

description:
mAdb experiment ID: 28639
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-01


title: E2f1-11_Cy3

description:
mAdb experiment ID: 29631
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-11


title: E2f1-11_Cy5

description:
mAdb experiment ID: 29632
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-11


title: E2f1-09_Cy3

description:
mAdb experiment ID: 25650
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v2p18_092901
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-09


title: E2f1-07_Cy5

description:
mAdb experiment ID: 26259
"HCC from E2f1 mono transgenic mouse, no duplication of microarray experiment"
Array Print: Mm-FCRF-GEM2-v2p18_092901
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-07


title: Myc-01_Cy5

description:
mAdb experiment ID: 28484
HCC from Myc mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc Transgenic
Treatment_Agent: NO
Sample: Myc-01


title: E2f1-10_Cy5

description:
mAdb experiment ID: 25652
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v2p18_092901
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-10


title: E2f1-05_Cy3

description:
mAdb experiment ID: 34182
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-05


title: E2f1-05_Cy5

description:
mAdb experiment ID: 34181
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-05


title: E2f1-04_Cy5

description:
mAdb experiment ID: 28646
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-04


title: E2f1-02_Cy5

description:
mAdb experiment ID: 28642
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-02


title: E2f1-04_Cy3

description:
mAdb experiment ID: 28645
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-04


title: E2f1-03_Cy3

description:
mAdb experiment ID: 34178
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-03


title: Myc/Tgfa-10_Cy3

description:
mAdb experiment ID: 32268
HCC from Myc/Tgfa double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/Tgfa double Transgenic
Treatment_Agent: NO
Sample: Myc/Tgfa-10


title: E2f1-06_Cy3

description:
mAdb experiment ID: 29630
"HCC from E2f1 mono transgenic mouse, no duplication of microarray experiment"
Array Print: Mm-FCRF-GEM2-v5.2p10_022502
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-06


title: E2f1-03_Cy5

description:
mAdb experiment ID: 34179
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-03


title: DENA-03_Cy5

description:
mAdb experiment ID: 33466
2 month-old mouse was injected once intraperitoneally with DENA (20 mg/kg body wt)
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: DENA
Sample: DENA-03


title: CIP-02_Cy5

description:
mAdb experiment ID: 33470
"Mouse fed ciprofibrate, a synthetic peroxisome proliferator in powdered chow at a concentration of 0.025% (w/w) for 19 months."
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: Ciprofibrate
Sample: CIP-02


title: DENA-01_Cy5

description:
mAdb experiment ID: 33462
2 month-old mouse was injected once intraperitoneally with DENA (20 mg/kg body wt)
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: DENA
Sample: DENA-01


title: DENA-03_Cy3

description:
mAdb experiment ID: 33467
2 month-old mouse was injected once intraperitoneally with DENA (20 mg/kg body wt)
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: DENA
Sample: DENA-03


title: E2f1-01_Cy3

description:
mAdb experiment ID: 28640
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v3p14_120601
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-01


title: CIP-03_Cy5

description:
mAdb experiment ID: 33472
"Mouse fed ciprofibrate, a synthetic peroxisome proliferator in powdered chow at a concentration of 0.025% (w/w) for 19 months."
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: Ciprofibrate
Sample: CIP-03


title: DENA-02_Cy5

description:
mAdb experiment ID: 33464
2 month-old mouse was injected once intraperitoneally with DENA (20 mg/kg body wt)
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: DENA
Sample: DENA-02


title: CIP-03_Cy3

description:
mAdb experiment ID: 33473
"Mouse fed ciprofibrate, a synthetic peroxisome proliferator in powdered chow at a concentration of 0.025% (w/w) for 19 months."
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: Ciprofibrate
Sample: CIP-03


title: DENA-01_Cy3

description:
mAdb experiment ID: 33463
2 month-old mouse was injected once intraperitoneally with DENA (20 mg/kg body wt)
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: DENA
Sample: DENA-01


title: CIP-01_Cy3

description:
mAdb experiment ID: 33469
"Mouse fed ciprofibrate, a synthetic peroxisome proliferator in powdered chow at a concentration of 0.025% (w/w) for 19 months."
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: Ciprofibrate
Sample: CIP-01


title: CIP-01_Cy5

description:
mAdb experiment ID: 33468
"Mouse fed ciprofibrate, a synthetic peroxisome proliferator in powdered chow at a concentration of 0.025% (w/w) for 19 months."
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: Ciprofibrate
Sample: CIP-01


title: CIP-02_Cy3

description:
mAdb experiment ID: 33471
"Mouse fed ciprofibrate, a synthetic peroxisome proliferator in powdered chow at a concentration of 0.025% (w/w) for 19 months."
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: Ciprofibrate
Sample: CIP-02


title: Acox1-26_Cy5

description:
mAdb experiment ID: 33460
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-26


title: Acox1-26_Cy3

description:
mAdb experiment ID: 33461
HCC from Acox1 knockout mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Acox1 KO
Treatment_Agent: NO
Sample: Acox1-26


title: CBCD34_setF_4hr

city: New York

first: Agnes

last: Viale

state: NY

address: 1275 York Avenue

department: Molecular Biology

institute: Memorial Sloan Kettering Cancer Center

description:
Total RNA
RNeasy extraction
Two rounds amplification (RT+IVT) Ambion MessageAmp kit

source_name: umbilical cord blood CD34+ cells, 4 hrs TGF-beta treatment


title: CBCD34_setD_4hr


title: CBCD34_setF2hr

source_name: umbilical cord blood CD34+ cells, 2 hrs TGF-beta treatment


title: CBCD34_setC_2hr


title: CBCD34_setC_4hr


title: CBCD34_setE_0hr

source_name: Umbilical cord blood CD34+ cells


title: CBCD34_setF_0hr

source_name: umbilical cord blood CD34+ cells


title: CBCD34_setE_2hr


title: CBCD34_setC_0hr

description:
Total RNA
RNeasy extraction
Two rounds amplification (Rt+IVT) Ambion MessageAmp kit


title: Liver, Intermittent Hypoxia 4

status: Public on Oct 27 2004

city: Baltimore

first: Dmitry

middle: N

last: Grigoryev

institute: JHU

description:
Total mRNA from liver tissues, strain: C57BL/6J- Lepob, subjected to intermittent hypoxia for 12 weeks
Keywords = Mus musculus
Keywords = liver

source_name: Liver


title: Liver, Normoxia 3

description:
Total mRNA from liver tissues, strain: C57BL/6J- Lepob
Keywords = Mus musculus, liver


title: Liver, Intermittent Hypoxia 1


title: Liver, Intermittent Hypoxia 3


title: Liver, Intermittent Hypoxia 2


title: Liver, Normoxia 5


title: CBCD34_setD_0hr


title: DENA-02_Cy3

description:
mAdb experiment ID: 33465
2 month-old mouse was injected once intraperitoneally with DENA (20 mg/kg body wt)
Array Print: Mm-FCRF-GEM2-v6p9_070902
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: WT
Treatment_Agent: DENA
Sample: DENA-02


title: Liver, Normoxia 1


title: Liver, Normoxia 4


title: body wall 6

city: Cleveland

first: Feng-Qi

last: An

state: OH

address: 10900 Euclid Avenue

department: Pathology

institute: Case Western Reserve University

description:
Gene expression profiling in DG75 cell line.
Gene expression profiling of three PEL cell lines compare to three Burkitt's lymphoma lines to figure out the changed genes under KSHV latent infection.
RNA was extracted using RNAzol. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA.
Keywords = DG75,KSHV,LANA,Gene expression profiling.

source_name: DG75 cell


title: E2f1-02_Cy3

description:
mAdb experiment ID: 28641
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v5.2p7_022202
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-02


title: E2f1-01_Cy5

description:
mAdb experiment ID: 34176
HCC from E2f1 mono transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: E2f1 Transgenic
Treatment_Agent: NO
Sample: E2f1-01


title: Liver, Intermittent Hypoxia 5


title: body wall 5

description:
Gene expression profiling in BJAB cell line.
Gene expression profiling of three PEL cell lines compare to three Burkitt's lymphoma lines to figure out the changed genes under KSHV latent infection.
RNA was extracted using RNAzol. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA.
Keywords = BJAB,KSHV,LANA,Gene expression profiling.

source_name: BJAB cell


title: HCC012_Cy3

description:
mAdb experiment ID: 39303

Array Print: Hs-OperonV2-vB1.1p4-020503
Tissue_type: Hepatocellular Carcinoma
Sample: HCC012
Sample_Description: subgroup B


title: body wall 3

description:
Gene expression profiling in BC-1 cell line.
Gene expression profiling of three PEL cell lines compare to three Burkitt's lymphoma lines to figure out the changed genes under KSHV latent infection.
RNA was extracted using RNAzol. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA.
Keywords = BC-1,KSHV,LANA,Gene expression profiling.

source_name: BC-1 cell


title: body wall 4

description:
Gene expression profiling in Raji cell line.
Gene expression profiling of three PEL cell lines compare to three Burkitt's lymphoma lines to figure out the changed genes under KSHV latent infection.
RNA was extracted using RNAzol. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA.
Keywords = Raji,KSHV,LANA,Gene expression profiling.

source_name: Raji cell


title: Bovine blood gamma/delta T cell stimulation: exp1 data

description:
Blood gamma/delta T cells were purfiied from holstein calves less than six months old. Blood from 4 individual calves were pooled and gamma/delta T cells purified by immunomagnetic separation, rested in RPMI medium for 12h, and underwent ConA & hIL-2 stimulation. Total RNAs were extracted by using Trizol reagents. 15 ug of total RNA was used for cDNA synthesis and microarray hybridization.
Keywords = Gamma delta
Keywords = ConA
Keywords = IL-2
Keywords = apoptosis
Lot batch = experiment 1

source_name: bovine blood gamma/delta T cells: COnA & hIL-2 stimulated (6h post-stimulation)


title: TEx15ni

status: Public on Oct 26 2004

first: Michelle

last: Kittleson

address: Carnegie 568, 600 North Wolfe Street

department: Internal Medicine, Division of Cardiology

institute: Johns Hopkins Medical Institutions

description: Expanted heart, nonischemic cardiomyopathy

source_name: Human heart


title: body wall 1

description:
Gene expression profiling in BCBL-1 cell line.
Gene expression profiling of three PEL cell lines compare to three Burkitt's lymphoma lines to figure out the changed genes under KSHV latent infection.
RNA was extracted using RNAzol. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA.
Keywords = BCBL-1,KSHV,LANA,Gene expression profiling.

source_name: BCBL-1 cell


title: body wall 2

description:
Gene expression profiling in BC-3 cell line.
Gene expression profiling of three PEL cell lines compare to three Burkitt's lymphoma lines to figure out the changed genes under KSHV latent infection.
RNA was extracted using RNAzol. Targets were produced using standard Affymetrix procedures from about 8ug of total RNA.
Keywords = BC-3,KSHV,LANA,Gene expression profiling.

source_name: BC-3 cell


title: T1008ni


title: TEx10i

description: Expanted heart, ischemic cardiomyopathy


title: TEx9i

description: Expanted heart, ischemic cardiomyopathy


title: TEx1i

description: Expanted heart, ischemic cardiomyopathy


title: N27

description: Unused donor heart


title: T1017i

description: Expanted heart, ischemic cardiomyopathy


title: Myc/E2f1-05_Cy3

description:
mAdb experiment ID: 33129
HCC from Myc/E2f1 double transgenic mouse
Array Print: Mm-FCRF-GEM2-v6p3_070302
Tissue_type: Hepatocellular Carcinoma
Transgenic_line: Myc/E2f1 double Transgenic
Treatment_Agent: NO
Sample: Myc/E2f1-05


title: T1001i

description: Expanted heart, ischemic cardiomyopathy


title: T1013i

description: Expanted heart, ischemic cardiomyopathy


title: LCH7ani

description: Pre-LVAD, nonischemic cardiomyopathy


title: Liver, Normoxia 2


title: N28

description: Unused donor heart


title: N22

description: Unused donor heart


title: N1

description: Unused donor heart


title: N26

description: Unused donor heart


title: N29

description: Unused donor heart


title: LCH2ani

description: Pre-LVAD, nonischemic cardiomyopathy


title: LCH3ani

description: Pre-LVAD, nonischemic cardiomyopathy


title: LC1026ni

description: Pre-LVAD, nonischemic cardiomyopathy


title: LCH5ani

description: Pre-LVAD, nonischemic cardiomyopathy


title: LCH6ani

description: Pre-LVAD, nonischemic cardiomyopathy


title: LCH1ani

description: Pre-LVAD, nonischemic cardiomyopathy


title: LCH4ani

description: Pre-LVAD, nonischemic cardiomyopathy


title: Mouse liver (MoLi.231x)

type: MPSS

city: Hayward

first: Daixing

last: Zhou

state: CA

address: 25861 Industrial Blvd

department: Bioinformatics

institute: Solexa

description:
Strain: C57BL6
Mouse liver total RNA (MoLi.231x) received from National Human Genome Research Institute was analyzed through Bioanalyzer and passed our quality control test.  The mRNA was processed according to the MPSS protocol as outlined in the previous publications (Brenner, S., et al. (2000) Proc Natl Acad Sci U S A 97(4): 1665-1670 and Brenner, S. et al., Nat. Biotechnol 18(6): 630-634).  Briefly, the mRNA was reverse transcribed and the cDNA was digested with Dpn II. The 20 bases adjacent to the 3? most Dpn II site was cloned into a Megaclone vector.  The resulting library was amplified and loaded onto microbeads. About 1.6 million microbeads were loaded into each flow cell and the signature sequences were determined by a series of enzymatic reactions as outlined in the above publications. The abundance for each signature was converted to transcripts per million (tpm) for the purpose of comparisons between samples.
Cells/tissue:
Library MoLi.231x.sig21
Cell type Mouse liver
Source NHGRI
RNA isolation LYNX mRNA QC passed
cDNA library:
Library 	DpnII restriction - (signature cloning using MmeI)
Sequence length	20 bp
MPSS:
runs
MoLi.231x_sig21.4791T.b-20	12/11/2003	404736	4303
MoLi.231x_sig21.4791T.a-20	12/10/2003	401571	4990
MoLi.231x_sig21.4791W.b-20	12/9/2003	493005	6186
MoLi.231x_sig21.4791W.a-20	12/9/2003	533054	6468
Run group:
Total Beads successfully sequenced - 1832366
Processed Signatures - 7105
Transcripts 3'-most (Canonical) Signatures - 4864
Lot batch =

source_name: Mouse liver total RNA


title: mouse liver (MoLi.251N)

description:
Strain: C57BL6
mouse liver total RNA (MoLi.251N) received from National Human Genome Research Institute was analyzed through Bioanalyzer and passed our quality control test.  The mRNA was processed according to the MPSS protocol as outlined in the previous publications (Brenner, S., et al. (2000) Proc Natl Acad Sci U S A 97(4): 1665-1670 and Brenner, S. et al., Nat. Biotechnol 18(6): 630-634).  Briefly, the mRNA was reverse transcribed and the cDNA was digested with Dpn II. The 20 bases adjacent to the 3? most Dpn II site was cloned into a Megaclone vector.  The resulting library was amplified and loaded onto microbeads. About 1.6 million microbeads were loaded into each flow cell and the signature sequences were determined by a series of enzymatic reactions as outlined in the above publications. The abundance for each signature was converted to transcripts per million (tpm) for the purpose of comparisons between samples.
Cells/tissue:
Library MoLi.251N.sig21
Cell type mouse liver
Source NHGRI
RNA isolation LYNX mRNA QC passed
cDNA library:
Library 	DpnII restriction - (signature cloning using MmeI)
Sequence length	20 bp
MPSS:
runs
MoLi.251N_sig21.4790W.a-20	12/11/2003	577981	10493
MoLi.251N_sig21.4790W.b-20	12/10/2003	586656	12015
MoLi.251N_sig21.4790T.b-20	12/9/2003	461433	8764
MoLi.251N_sig21.4790T.a-20	12/9/2003	493576	9009
Run group:
Total Beads successfully sequenced - 2119646
Processed Signatures - 12964
Transcripts 3'-most (Canonical) Signatures - 7295
Lot batch =

source_name: mouse liver total RNA


title: LC1007i

description: Pre-LVAD, ischemic cardiomyopathy


title: LC1025ni

description: Pre-LVAD, nonischemic cardiomyopathy


title: LC1003ni

description: Pre-LVAD, nonischemic cardiomyopathy


title: LC1024ni

description: Pre-LVAD, nonischemic cardiomyopathy


title: LC1022ni

description: Pre-LVAD, nonischemic cardiomyopathy


title: mouse liver (MoLi.241P)

description:
Strain: C57BL6
mouse liver total RNA (MoLi.241P) received from National Human Genome Research Institute was analyzed through Bioanalyzer and passed our quality control test.  The mRNA was processed according to the MPSS protocol as outlined in the previous publications (Brenner, S., et al. (2000) Proc Natl Acad Sci U S A 97(4): 1665-1670 and Brenner, S. et al., Nat. Biotechnol 18(6): 630-634).  Briefly, the mRNA was reverse transcribed and the cDNA was digested with Dpn II. The 20 bases adjacent to the 3? most Dpn II site was cloned into a Megaclone vector.  The resulting library was amplified and loaded onto microbeads. About 1.6 million microbeads were loaded into each flow cell and the signature sequences were determined by a series of enzymatic reactions as outlined in the above publications. The abundance for each signature was converted to transcripts per million (tpm) for the purpose of comparisons between samples.
Cells/tissue:
Library MoLi.241P.sig21
Cell type mouse liver
Source NHGRI
RNA isolation LYNX mRNA QC passed
cDNA library:
Library 	DpnII restriction - (signature cloning using MmeI)
Sequence length	20 bp
MPSS:
runs
MoLi.241P_sig21.4789W.a-20	12/11/2003	632855	8570
MoLi.241P_sig21.4789W.b-20	12/9/2003	792128	10854
MoLi.241P_sig21.4789T.b-20	12/9/2003	600288	8237
MoLi.241P_sig21.4789T.a-20	12/9/2003	551161	7234
Run group:
Total Beads successfully sequenced - 2576432
Processed Signatures - 11467
Transcripts 3'-most (Canonical) Signatures - 7658
Lot batch =


title: BLK.CL4 (MoBC.30PN)

description:
Strain: C57BL6
BLK.CL4 total RNA (MoBC.30PN) received from National Human Genome Research Institute was analyzed through Bioanalyzer and passed our quality control test.  The mRNA was processed according to the MPSS protocol as outlined in the previous publications (Brenner, S., et al. (2000) Proc Natl Acad Sci U S A 97(4): 1665-1670 and Brenner, S. et al., Nat. Biotechnol 18(6): 630-634).  Briefly, the mRNA was reverse transcribed and the cDNA was digested with Dpn II. The 20 bases adjacent to the 3? most Dpn II site was cloned into a Megaclone vector.  The resulting library was amplified and loaded onto microbeads. About 1.6 million microbeads were loaded into each flow cell and the signature sequences were determined by a series of enzymatic reactions as outlined in the above publications. The abundance for each signature was converted to transcripts per million (tpm) for the purpose of comparisons between samples.
Cells/tissue:
Library MoBC.30PN.sig22
Cell type BLK.CL4
Source NHGRI
RNA isolation LYNX mRNA QC passed
cDNA library:
Library 	DpnII restriction - (signature cloning using MmeI)
Sequence length	20 bp
MPSS:
runs
MoBC.30PN_sig22.4812W.a-20	12/18/2003	598971	15209
MoBC.30PN_sig22.4812T.b-20	12/18/2003	593928	12778
MoBC.30PN_sig22.4812T.a-20	12/18/2003	527824	12235
MoBC.30PN_sig22.4812W.b-20	12/18/2003	577917	17594
Run group:
Total Beads successfully sequenced - 2298640
Processed Signatures - 16727
Transcripts 3'-most (Canonical) Signatures - 11129
Lot batch =

source_name: BLK.CL4 total RNA


title: IDCM6

description: Explanted heart, nonischemic cardiomyopathy


title: T1015i

description: Expanted heart, ischemic cardiomyopathy


title: IDCM5


title: IDCM1


title: IDCM4


title: IDCM2


title: BLK.CL4 (MoBC.29xx)

description:
Strain: C57BL6
BLK.CL4 total RNA (MoBC.29xx) received from National Human Genome Research Institute was analyzed through Bioanalyzer and passed our quality control test.  The mRNA was processed according to the MPSS protocol as outlined in the previous publications (Brenner, S., et al. (2000) Proc Natl Acad Sci U S A 97(4): 1665-1670 and Brenner, S. et al., Nat. Biotechnol 18(6): 630-634).  Briefly, the mRNA was reverse transcribed and the cDNA was digested with Dpn II. The 20 bases adjacent to the 3? most Dpn II site was cloned into a Megaclone vector.  The resulting library was amplified and loaded onto microbeads. About 1.6 million microbeads were loaded into each flow cell and the signature sequences were determined by a series of enzymatic reactions as outlined in the above publications. The abundance for each signature was converted to transcripts per million (tpm) for the purpose of comparisons between samples.
Cells/tissue:
Library MoBC.29xx.sig21
Cell type BLK.CL4
Source NHGRI
RNA isolation LYNX mRNA QC passed
cDNA library:
Library 	DpnII restriction - (signature cloning using MmeI)
Sequence length	20 bp
MPSS:
runs
MoBC.29xx_sig21.4788W.a-20	12/17/2003	588761	13368
MoBC.29xx_sig21.4788T.b-20	12/9/2003	451422	11263
MoBC.29xx_sig21.4788T.a-20	12/9/2003	429623	11932
MoBC.29xx_sig21.4788W.b-20	12/9/2003	531391	11722
Run group:
Total Beads successfully sequenced - 2001197
Processed Signatures - 15689
Transcripts 3'-most (Canonical) Signatures - 10081
Lot batch =


title: IDCM3


title: BLK.CL4 (MoBC.31Nc)

description:
Strain: C57BL6
BLK.CL4 total RNA (MoBC.31Nc) received from National Human Genome Research Institute was analyzed through Bioanalyzer and passed our quality control test.  The mRNA was processed according to the MPSS protocol as outlined in the previous publications (Brenner, S., et al. (2000) Proc Natl Acad Sci U S A 97(4): 1665-1670 and Brenner, S. et al., Nat. Biotechnol 18(6): 630-634).  Briefly, the mRNA was reverse transcribed and the cDNA was digested with Dpn II. The 20 bases adjacent to the 3? most Dpn II site was cloned into a Megaclone vector.  The resulting library was amplified and loaded onto microbeads. About 1.6 million microbeads were loaded into each flow cell and the signature sequences were determined by a series of enzymatic reactions as outlined in the above publications. The abundance for each signature was converted to transcripts per million (tpm) for the purpose of comparisons between samples.
Cells/tissue:
Library MoBC.31Nc.sig21
Cell type BLK.CL4
Source NHGRI
RNA isolation LYNX mRNA QC passed
cDNA library:
Library 	DpnII restriction - (signature cloning using MmeI)
Sequence length	20 bp
MPSS:
runs
MoBC.31Nc_sig21.4792W.d-20	12/17/2003	485122	18365
MoBC.31Nc_sig21.4792W.c-20	12/16/2003	540475	19063
MoBC.31Nc_sig21.4792T.b-20	12/11/2003	614438	20298
MoBC.31Nc_sig21.4792T.a-20	12/11/2003	544180	20436
Run group:
Total Beads successfully sequenced - 2184215
Processed Signatures - 23657
Transcripts 3'-most (Canonical) Signatures - 12762
Lot batch =


title: CBCD34_setE_4hr

description:
Total RNA
RNeasy extraction
Two rounds amplification (RT+IVT) Ambion MessageAmp kit


title: Hypocotyl dark, hn2

status: Public on Oct 24 2004

city: NEW HAVEN

first: Ligeng

last: Ma

state: CT

address: 165 Prospect

department: Molecular, Cellular & Developmental Biology

institute: Yale University

description: Hypocotyl dark vs Cultured cell

organism: Arabidopsis thaliana

source_name: Cultured cell

source_name: Hypocotyl dark


title: Stem, stp1

description: Stem vs cultured cell

source_name: Stem


title: Stem, stp2

description: Stem vs cultured cell


title: LC1008ni

description: Pre-LVAD, nonischemic cardiomyopathy


title: Stem, stp3

description: Stem vs cultured cell


title: Stamen, smn3

description: Stamen vs cultured cell

source_name: cultured cell

source_name: stamen


title: Silique 8DPP, s8n3

description: Silique 8DPP vs cultured cell

source_name: silique 8DPP


title: Stamen, smn1

description: Stamen vs cultured cell


title: Silique 8DPP, s8n2

description: Silique 8DPP vs cultured cell


title: Silique 3DPP, s3n1

description: Silique 3DPP vs cultured cell

source_name: silique 3DPP


title: Hypocotyl dark, hn1

description: Hypocotyl dark vs Cultured cell


title: Sepal, sn2

description: Sepal vs cultured cell

source_name: Sepal


title: Silique 3DPP, s3n3

description: Silique 3DPP vs cultured cell


title: Stamen, smn2

description: Stamen vs cultured cell


title: LC1021i

description: Pre-LVAD, ischemic cardiomyopathy


title: Silique 8DPP, s8n1

description: Silique 8DPP vs cultured cell


title: Root light vs dark, rldp2

description: Root light vs root dark

source_name: root light

source_name: root dark


title: Root light, rlp1

description: Root light vs cultured cell


title: Root light vs dark, rldp1

description: Root light vs root dark


title: Root dark, rdn2

description: Root dark vs cultured cell


title: Root light, rln1

description: Root light vs cultured cell


title: Rosette leaf, rfp1

description: Rosette leaf vs cultured cell

source_name: Rosette leaf


title: Root dark, rdn1

description: Root dark vs cultured cell


title: Pistil 1DPP, psn4

description: Pistil 1DPP vs cultured cell

source_name: Pistil 1DPP


title: LC1002i

description: Pre-LVAD, ischemic cardiomyopathy

source_name: Human heart


title: Pistil 1DPP, psn2

description: Pistil 1DPP vs cultured cell


title: Pistil 1DBP, pin2

description: Pistil 1DBP vs cultured cell

source_name: Pistil 1DBP


title: Pistil 1DBP, pin3

description: Pistil 1DBP vs cultured cell


title: Silique 3DPP, s3n2

description: Silique 3DPP vs cultured cell


title: Pistil 1DPP, psn3

description: Pistil 1DPP vs cultured cell


title: Rosette leaf, rfp3

description: Rosette leaf vs cultured cell


title: Petal, pn3

description: Petal vs cultured cell

source_name: Petal


title: Hypocotyl light, hln2

description: Hypocotyl light vs Cultured cell

source_name: hypocotyl light


title: Hypocotyl light, hln1

description: Hypocotyl light vs Cultured cell


title: Germinating seed, gn3

description: Germinating seed vs Cultured cell

source_name: germinating seed


title: Hypocotyl, hldn1

description: Hypocotyl light vs Hypocotyl dark

source_name: hypocotyl dark


title: Cotyledon dark, n3

description: Cotyledon dark vs cultured cell

source_name: Cotyledon dark


title: Cotyledon, cn2

description: Cotyledon light vs Cultured cell

source_name: cotyledon light


title: Cotyledon, CP1

description: Cotyledon light vs Cotyledon dark

source_name: Cotyledon light


title: Cotyledon, CP2

description: Cotyledon light vs Cotyledon dark


title: CGH5_26, XX+XY

status: Public on Oct 23 2004

type: genomic

city: Lisbon

first: Joana

last: Cardoso

address: Av. Prof Egaz Moniz

country: Portugal

institute: Faculty of Medicine

description: 2ng of a mixture 1:1 of commercial female DNA (XX) and commercial male DNA (XY) were amplified with Phi-29 enzyme (GenomiPhi kit-Amersham) in order to simulate the amounts of a microdissected sample. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

molecule: genomic DNA

source_name: 2ng of Phi-29amplified mixture 1:1 of commercial female DNA XX (Promega) and commercial male DNA XY (Promega)

source_name: commercial female DNA (Promega)


title: CGH4_74, XXX+XX

description: 2ng of a lymphoblastoid cell line containing a known X trisomy (XXX) were amplified with Phi-29 enzyme (GenomiPhi kit-Amersham) in order to simulate the amounts of a microdissected sample. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: 2ng of Phi-29amplified cell line DNA XXX


title: CGH4_75, XXX+XX

description: 2ng of a mixture 1:1 of commercial female DNA (XX) and of a lymphoblastoid cell line containing a known X trisomy (XXX) were amplified with Phi-29 enzyme (GenomiPhi kit-Amersham) in order to simulate the amounts of a microdissected sample. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: 2ng of Phi-29amplified mixture 1:1 of commercial female DNA XX (Promega) and a cell line DNA XXX


title: CGH5_27, XY

description: 2ng commercial male DNA (XY) were amplified with of Phi-29 enzyme (GenomiPhi kit-Amersham) in order to simulate the amounts of a microdissected sample. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: 2ng of Phi-29amplified commercial male DNA (Promega)


title: CGH4_73, 5cl20, XY

description: 2ng of sample 5cl20 DNA (XY), containing a know trisomy over 5 clones on chr20, were amplified with of Phi-29 enzyme (GenomiPhi kit-Amersham) in order to simulate the amounts of a microdissected sample. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: 2ng of Phi-29amplified male sample 5cl20 DNA

source_name: commercial male DNA (Promega)


title: Rosette leaf, rfp2

description: Rosette leaf vs cultured cell

source_name: Rosette leaf

source_name: cultured cell


title: Petal, pn1

description: Petal vs cultured cell

source_name: Cultured cell


title: Hypocotyl, hldn2

description: Hypocotyl light vs Hypocotyl dark


title: Pistil 1DPP, psn1

description: Pistil 1DPP vs cultured cell

source_name: Pistil 1DPP


title: Petal, pn2

description: Petal vs cultured cell

source_name: Petal


title: Cotyledon, cn1

description: Cotyledon light vs Cultured cell


title: Germinating seed, gn1

description: Germinating seed vs Cultured cell

source_name: germinating seed


title: Cotyledon dark, n2

description: Cotyledon dark vs cultured cell


title: CGH4_61, NC3, XX

description: Phi-29amplified microdissected normal colon mucosa DNA sample(NC3, XX) from an healthy control female individual. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: Phi-29amplified microdissected normal colon mucosa DNA (NC3)


title: Cauline leaf, p3

description: Cauline leaf vs cultured cell

source_name: Cauline leaf


title: Pistil 1DBP, pin1

description: Pistil 1DBP vs cultured cell

source_name: Pistil 1DBP


title: Cauline leaf, p1

description: Cauline leaf vs cultured cell


title: Germinating seed, gn2

description: Germinating seed vs Cultured cell


title: CGH4_60, NC2, XX

description: Phi-29amplified microdissected normal colon mucosa DNA sample(NC2, XX) from an healthy control female individual. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: Phi-29amplified microdissected normal colon mucosa DNA (NC2)


title: CGH3_1, D5_14, XY

description: Phi-29amplified microdissected normal colon mucosa DNA sample(D5_14, XY) from a male individual affected by Familial Adenomatous Polyposis. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: Phi-29amplified microdissected normal colon mucosa DNA (D5_14)


title: CGH3_23, D5_1, XY

description: Phi-29amplified microdissected dysplatic colon mucosa DNA sample(D5_1, XY) from a male individual affected by Familial Adenomatous Polyposis. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: Phi-29amplified microdissected tumor colon mucosa DNA (D5_1)


title: CGH4_59, NC1, XY

description: Phi-29amplified microdissected normal colon mucosa DNA sample(NC1, XY) from an healthy control male individual. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: Phi-29amplified microdissected normal colon mucosa DNA (NC1)


title: CGH3_3 XX

description: 2ng commercial female DNA (XX) were amplified with of Phi-29 enzyme (GenomiPhi kit-Amersham) in order to simulate the amounts of a microdissected sample. Details of the experiment are available within the Nucleic Acid Research, 2004 manuscript "Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH", by Cardoso J. et al.

source_name: 2ng of Phi-29amplified commercial female DNA (Promega)


title: Cotyledon dark, n1

description: Cotyledon dark vs cultured cell

source_name: Cotyledon dark


title: CGH3_2 XY

source_name: 2ng of Phi-29amplified commercial male DNA (Promega)


title: CGH3_4 XY

source_name: commercial male DNA (Promega)


title: Sepal, sn1

description: Sepal vs cultured cell

source_name: Sepal


title: CGH3_1 XX


title: Untreated Raw 264.7 cells 4 hr vs Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated RAw 264.7 cells 4 hr.(set 3)

city: Pasadena

first: Sangdun

last: Choi

address: 1200 E. California Blvd

department: Biology

institute: California Institute of Technology

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from untreated RAW 264.7 cells was labeled with Cyanine-3 (green).

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) and 2MA (500uM) treated RAW 264.7 cells was label with Cyanine-5 (red).


title: Untreated RAW 264.7 cells 4 hours vs Lipopolysaccharide (LPS) treated RAW 264.7 cells 4 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Interferon-gamma (IFG) treated RAW 264.7 cells 4 hours vs untreated RAW 264.7 cells 4 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from Interferon-gamma (5nM) treated RAW 264.7 cells was labeled with Cyanine-3 (green).

source_name: Total RNA from untreated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Untreated RAW 264.7 cells 4 hours vs 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 4 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Untreated RAW 264.7 cells 4 hr vs Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 4 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) and IFG (5nM) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 4 hours vs untreated RAW 264.7 cells 4 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from  2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells was labeled with Cyanine-3 (green).


title: Lipopolysaccharide (LPS) treated RAW 264.7 cells 4 hours vs untreated RAW 264.7 cells 4 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) treated RAW 264.7 cells was labeled with Cyanine-3 (green).


title: Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 4 hr vs untreated RAW 264.7 cells 4 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) and IFG (5nM) treated RAW 264.7 cells was labeled with Cyanine-3 (green).


title: Untreated RAW 264.7 cells 2 hr vs Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 2 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.


title: Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated Raw 264.7 cells 1 hr vs untreated RAw 264.7 cells 1 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) and 2MA (500uM) treated RAW 264.7 cells was label with Cyanine-3 (green).


title: Untreated RAW 264.7 cells 2 hours vs Interferon-gamma (IFG) treated RAW 264.7 cells 2 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.

source_name: Total RNA from Interferon-gamma (5nM) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Untreated Raw 264.7 cells 1 hr vs Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated RAw 264.7 cells 1 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 1 hour.


title: Untreated Raw 264.7 cells 2 hr vs Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated RAw 264.7 cells 2 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.


title: 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 2 hours vs untreated RAW 264.7 cells 2 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from  2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated Raw 264.7 cells 4 hr vs untreated RAw 264.7 cells 4 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.


title: Untreated RAW 264.7 cells 4 hours vs Interferon-gamma (IFG) treated RAW 264.7 cells 4 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.


title: Untreated RAW 264.7 cells 2 hours vs 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 2 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.


title: 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 1 hour vs untreated RAW 264.7 cells 1 hour. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from  2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.


title: Untreated RAW 264.7 cells 2 hours vs Lipopolysaccharide (LPS) treated RAW 264.7 cells 2 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 2 hours.


title: Interferon-gamma (IFG) treated RAW 264.7 cells 2 hours vs untreated RAW 264.7 cells 2 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 2 hr vs untreated RAW 264.7 cells 2 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Untreated RAW 264.7 cells 1 hour vs Lipopolysaccharide (LPS) treated RAW 264.7 cells 1 hour. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 1 hour.


title: Untreated RAW 264.7 cells 1 hr vs Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 1 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 1 hour.


title: Interferon-gamma (IFG) treated RAW 264.7 cells 1 hour vs untreated RAW 264.7 cells 1 hour. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.


title: Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 1 hr vs untreated RAW 264.7 cells 1 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.


title: Lipopolysaccharide (LPS) treated RAW 264.7 cells 1 hour vs untreated RAW 264.7 cells 1 hour. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.


title: Untreated RAW 264.7 cells 1 hour vs Interferon-gamma (IFG) treated RAW 264.7 cells 1 hour. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 1 hour.


title: Cauline leaf, p2

description: Cauline leaf vs cultured cell

source_name: Cauline leaf

source_name: Cultured cell


title: Untreated RAW 264.7 cells 1 hour vs 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 1 hour. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 1 hour.


title: Untreated RAW 264.7 cells 30 minutes vs Lipopolysaccharide (LPS) treated RAW 264.7 cells 30 minutes. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 30 minutes.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 30 minutes.


title: Lipopolysaccharide (LPS) treated RAW 264.7 cells 30 minutes vs untreated RAW 264.7 cells 30 minutes. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 30 minutes.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 30 minutes.


title: Lipopolysaccharide (LPS) treated RAW 264.7 cells 2 hours vs untreated RAW 264.7 cells 2 hours. (set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Interferon-gamma (IFG) treated RAW 264.7 cells 4 hours vs untreated RAW 264.7 cells 4 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.


title: Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 4 hr vs untreated RAW 264.7 cells 4 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.


title: Untreated RAW 264.7 cells 4 hr vs Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 4 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.


title: Lipopolysaccharide (LPS) treated RAW 264.7 cells 4 hours vs untreated RAW 264.7 cells 4 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.


title: Untreated RAW 264.7 cells 4 hours vs 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 4 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.


title: Interferon-gamma (IFG) treated RAW 264.7 cells 2 hours vs untreated RAW 264.7 cells 2 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Untreated RAW 264.7 cells 2 hours vs Interferon-gamma (IFG) treated RAW 264.7 cells 2 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.


title: Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated Raw 264.7 cells 2 hr vs untreated RAw 264.7 cells 2 hr.(set 3)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 2 hours vs untreated RAW 264.7 cells 2 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Untreated RAW 264.7 cells 2 hr vs Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 2 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.


title: Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated Raw 264.7 cells 4 hr vs untreated RAw 264.7 cells 4 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.


title: Untreated RAW 264.7 cells 4 hours vs Lipopolysaccharide (LPS) treated RAW 264.7 cells 4 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 4 hours.


title: Untreated Raw 264.7 cells 2 hr vs Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated RAw 264.7 cells 2 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.


title: Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated Raw 264.7 cells 2 hr vs untreated RAw 264.7 cells 2 hr.(set 2)


title: Untreated RAW 264.7 cells 4 hours vs Interferon-gamma (IFG) treated RAW 264.7 cells 4 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.


title: Untreated RAW 264.7 cells 2 hours vs 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 2 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours. !Sample_author = Mi Sook,, Chang


title: Untreated Raw 264.7 cells 1 hr vs Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated RAw 264.7 cells 1 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 1 hour.


title: Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 2 hr vs untreated RAW 264.7 cells 2 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated Raw 264.7 cells 1 hr vs untreated RAw 264.7 cells 1 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.


title: Untreated RAW 264.7 cells 1 hr vs Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 1 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA LPS (100ng/100pM LPS binding protein) and IFG (5nM) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 4 hours vs untreated RAW 264.7 cells 4 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.


title: Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAW 264.7 cells 1 hr vs untreated RAW 264.7 cells 1 hr.(set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA untreated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Lipopolysaccharide (LPS) treated RAW 264.7 cells 2 hours vs untreated RAW 264.7 cells 2 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Untreated RAW 264.7 cells 2 hours vs Lipopolysaccharide (LPS) treated RAW 264.7 cells 2 hours. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 2 hours.


title: Untreated RAW 264.7 cells 1 hour vs 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 1 hour. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 1 hour.


title: Interferon-gamma (IFG) treated RAW 264.7 cells 1 hour vs untreated RAW 264.7 cells 1 hour. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.


title: 2-Methyl-thio-ATP (2MA) treated RAW 264.7 cells 1 hour vs untreated RAW 264.7 cells 1 hour. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.


title: 2-Methyl-thio-ATP treated Raw 264.7 cells 4 hours vs untreated RAw 264.7 cells 4 hours. (set 1)


title: Untreated RAW 264.7 cells 1 hour vs Interferon-gamma (IFG) treated RAW 264.7 cells 1 hour. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA untreated RAW 264.7 cells was labeled with Cyanine-3 (green).


title: Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated Raw 264.7 cells 4 hr vs untreated RAw 264.7 cells 4 hr.(set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from untreated  RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Untreated RAW 264.7 cells 30 minutes vs Lipopolysaccharide (LPS) treated RAW 264.7 cells 30 minutes. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 30 minutes.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 30 minutes.

source_name: Total RNA from untreated RAW 264.7 cells was labeled with Cyanine-3 (green).


title: 2-Methyl-thio-ATP treated Raw 264.7 cells 2 hours vs untreated RAw 264.7 cells 2 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Untreated Raw 264.7 cells 2 hours vs Lipopolysaccharide (LPS) treated RAw 264.7 cells 2 hours. (set 1)

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Lipopolysaccharide (LPS) treated RAW 264.7 cells 1 hour vs untreated RAW 264.7 cells 1 hour. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.


title: Untreated Raw 264.7 cells 4 hours vs Interferon-gamma treated RAw 264.7 cells 4 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.


title: Untreated Raw 264.7 cells 4 hours vs 2-Methyl-thio-ATP treated RAw 264.7 cells 4 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from 2-Methyl-thio-ATP (500uM) treated  RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Untreated Raw 264.7 cells 4 hr vs Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAw 264.7 cells 4 hr.(set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.


title: Interferon-gamma treated Raw 264.7 cells 4 hours vs untreated RAw 264.7 cells 4 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from Interferon-gamma (5nM) treated RAW 264.7 cells was labeled with Cyanine-3 (green).

source_name: Total RNA from untreated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated Raw 264.7 cells 2 hr vs untreated RAw 264.7 cells 2 hr.(set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide(100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Untreated Raw 264.7 cells 2 hr vs Lipopolysaccharide(LPS) and Interferon-gamma(IFG) treated RAw 264.7 cells 2 hr.(set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) and IFG (5nM) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Untreated Raw 264.7 cells 4 hr vs Lipopolysaccharide (LPS) and 2-Methyl-thio-ATP treated RAw 264.7 cells 4 hr. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) and 2MA (500uM) treated RAW 264.7 cells was label with Cyanine-5 (red).


title: Untreated Raw 264.7 cells 2 hours vs Interferon-gamma treated RAw 264.7 cells 2 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Interferon-gamma (5nM) RAW 264.7 cells cultured for 2 hours.

source_name: Total RNA from Interferon-gamma (5nM) RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Lipopolysaccharide (LPS) and 2-Methyl-thio-ATP treated Raw 264.7 cells 4 hr vs untreated RAw 264.7 cells 4 hr. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.


title: Lipopolysaccharide treated Raw 264.7 cells 30 minutes vs untreated RAw 264.7 cells 30 minutes. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) RAW 264.7 cells cultured for 30 minutes.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 30 minutes.

source_name: Total RNA from Lipopolysaccharide (100ng/100pM LPS binding protein) RAW 264.7 cells was labeled with Cyanine-3 (green).


title: Untreated RAW 264.7 cells 1 hour vs Lipopolysaccharide (LPS) treated RAW 264.7 cells 1 hour. (set 2)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 1 hour.


title: Untreated Raw 264.7 cells 2 hours vs 2-Methyl-thio-ATP treated RAw 264.7 cells 2 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.

source_name: Total RNA from 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Untreated Raw 264.7 cells 4 hours vs Lipopolysaccharide (LPS) treated RAw 264.7 cells 4 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from  LPS (100ng/100pM LPS binding protein) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Interferon-gamma (5nM) treated Raw 264.7 cells 2 hours vs untreated RAw 264.7 cells 2 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.


title: Lipopolysaccharide (LPS) treated Raw 264.7 cells 2 hours vs untreated RAw 264.7 cells 2 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) treated RAW 264.7 cells was labeled with Cyanine-3 (green).


title: Untreated Raw 264.7 cells 4 hr vs Lipopolysaccharide(LPS) and 2-Methyl-thio-ATP treated RAw 264.7 cells 4 hr.(set 2)


title: Lipopolysaccharide (LPS) and 2-Methyl-thio-ATP treated Raw 264.7 cells 2 hr vs untreated RAw 264.7 cells 2 hr. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide(100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) and 2MA (500uM) treated RAW 264.7 cells was label with Cyanine-3 (green).


title: Untreated Raw 264.7 cells 2 hr vs Lipopolysaccharide (LPS) and 2-Methyl-thio-ATP treated RAw 264.7 cells 2 hr. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 2 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide(100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 2 hours.


title: bacteria 07

city: Sophia Antipolis

first: Chimene

last: Moreilhon

country: France

institute: CNRS

description: epithelial cells were in contact with S. aureus or not (control cells).

source_name: control 07

source_name: bacteria 07


title: Untreated RAW 264.7 cells 1 hour vs 2-Methyl-thio-ATP treated Raw 264.7 cells 1 hour . (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from 2-Methyl-thio-ATP (500uM) RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA from 2-Methyl-thio-ATP (500uM) RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Untreated Raw 264.7 cells 1 hr vs Lipopolysaccharide (LPS) and 2-Methyl-thio-ATP treated RAw 264.7 cells 1 hr. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and 2-Methyl-thio-ATP (500uM) treated RAW 264.7 cells cultured for 1 hour.


title: bacterial supernatant 08

description: epithelial cells were in contact with S. aureus supernatant or not (control cells).

source_name: control 08

source_name: bacterial supernatant 08


title: bacteria 03

source_name: bacteria 03

source_name: control 03


title: bacterial supernatant 12

source_name: control 12

source_name: bacterial supernatant 12


title: Untreated Raw 264.7 cells 1 hour vs Lipopolysaccharide (LPS) and Interferon-gamma (IFG) Raw 264.7 cells 1 hour. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA untreated RAW 264.7 cells was labeled with Cyanine-3 (green).

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) and IFG (5nM) RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Untreated Raw 264.7 cells 1 hour vs Interferon-gamma treated RAW 264.7 cells 1 hour . (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from Interferon-gamma (5nM) treated RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA from Untreated RAW 264.7 cells was labeled with Cyanine-3 (green).

source_name: Total RNA from Interferon-gamma (5nM) treated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Lipopolysaccharide (LPS) treated RAW 264.7 cells 1 hour vs Untreated Raw 264.7 cells 1 hour. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from lipopolysaccharide (100ng/100pM binding protein) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA from Untreated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: EP002

status: Public on Oct 22 2004

city: Berlin-Steglitz

first: Dirk

last: Carstanjen

state: Berlin

address: Krahmer Strasse 6

department: Molecular Genetics

country: Germany

institute: Institute for Molecular Pharmacology

description:
Mouse erythroid progenitors (EP) from bone marrow of 10 - 16 weeks old C57/Bl6 - S129Ola (mixed genetic background) purified by flow cytometry.
Lot batch = 3002162

source_name: EP


title: EP001


title: Lipopolysaccharide (LPS) and Interferon-gamma (IFG) Raw 264.7 cells 1 hour vs untreated Raw 264.7 cells 1 hour . (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) and Interferon-gamma (5nM) RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) and IFG (5nM) RAW 264.7 cells was labeled with Cyanine-3 (green).

source_name: Total RNA untreated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: bacteria 01

source_name: bacteria 01

source_name: control 01


title: bacterial supernatant 10

source_name: bacterial supernatant 10

source_name: control 10


title: bacterial supernatant 04

source_name: bacterial supernatant 04

source_name: control 04


title: bacteria 02

source_name: bacteria 02

source_name: control 02


title: bacteria 06

source_name: control 06

source_name: bacteria 06


title: Lipopolysaccharide (LPS) treated Raw 264.7 cells 4 hours vs untreated RAw 264.7 cells 4 hours. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng/100pM LPS binding protein) treated RAW 264.7 cells cultured for 4 hours.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 4 hours.

source_name: Total RNA from LPS (100ng/100pM LPS binding protein) treated RAW 264.7 cells was labeled with Cyanine-3 (green).

source_name: Total RNA from  untreated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: 2-Methyl-thio-ATP treated Raw 264.7 cells 1 hour vs untreated RAW 264.7 cells 1 hour. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from 2-Methyl-thio-ATP (500nM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA from 2-Methyl-thio-ATP (500uM) RAW 264.7 cells was labeled with Cyanine-3 (green).

source_name: Total RNA from untreated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: bacteria 05

source_name: control 05

source_name: bacteria 05


title: Fbn1Hom

status: Public on Oct 21 2004

first: Daniel

last: Judge

address: 720 Rutland Avenue

institute: Johns Hopkins University

description: Fbn1 C1039G/C1039G

source_name: Murine mitral valve


title: Fbn1WT

description: Fbn1 +/+


title: bacterial supernatant 09

source_name: bacterial supernatant 09

source_name: control 09


title: Fbn1Het1

description: Fbn1 C1039/+


title: bacterial supernatant 11

source_name: control 11

source_name: bacterial supernatant 11


title: Interferon-gamma treated RAW 264.7 cells 1 hour vs Untreated Raw 264.7 cells 1 hour. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Interferon-gamma(5nM) treated RAW 264.7 cells cultured for 1 hour.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 1 hour.

source_name: Total RNA from Interferon-gamma(5nM) treated RAW 264.7 cells was labeled with Cyanine-3 (green).

source_name: Total RNA from Untreated RAW 264.7 cells was labeled with Cyanine-5 (red).


title: Lipopolysaccharide (LPS) treated RAW 264.7 cells 30 mins vs Untreated Raw 264.7 cells 30 min. (set 1)

description:
All samples were gathered from mouse RAW 264.7 cells (macrophages). Control total RNA was extracted from Lipopolysaccharide (100ng of LPS/100pM of LPS binding protein) treated RAW 264.7 cells cultured for 30 minutes.
All samples were gathered from mouse RAW 264.7 cells (macrophages). Test total RNA was extracted from untreated RAW 264.7 cells cultured for 30 minutes.

source_name: Total RNA from LPS (100ng of LPS/100pM of LPS binding protein) treated RAW 264.7 cells was labeled with Cyanine-3 (green).


title: 16-4_16-3

status: Public on Oct 20 2004

city: Minamidai, Kawagoe

first: Toshiro

last: Saito

state: Saitama

department: Life Science Group

country: Japan

institute: Hitachi, Ltd.

description:
Sample Tissue: peripheral blood
Subject No.: 16
Disease: diabetes

source_name: after listening to a monotonous academic lecture without humor

source_name: before listening to a monotonous academic lecture without humor


title: 10-4_10-3

description:
Sample Tissue: peripheral blood
Subject No.: 10
Disease: diabetes


title: 17-4_17-3

description:
Sample Tissue: peripheral blood
Subject No.: 17
Disease: diabetes


title: 5-4_5-3

description:
Sample Tissue: peripheral blood
Subject No.: 5
Disease: diabetes


title: 6-4_6-3

description:
Sample Tissue: peripheral blood
Subject No.: 6
Disease: diabetes


title: 11-2_11-1

description:
Sample Tissue: peripheral blood
Subject No.: 11
Disease: diabetes

source_name: after listening to a Japanese comic story

source_name: before listening to a Japanese comic story